Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,511 | 329 | 51.9% |
| Consulting Fee | $4,450 | 2 | 22.0% |
| Travel and Lodging | $4,356 | 15 | 21.5% |
| Education | $662.18 | 17 | 3.3% |
| Gift | $284.77 | 1 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Verathon Inc. | $4,450 | 2 | $0 (2024) |
| Boston Scientific Corporation | $1,989 | 17 | $0 (2019) |
| PROCEPT BioRobotics Corporation | $1,980 | 4 | $0 (2024) |
| Axonics, Inc. | $1,482 | 10 | $0 (2022) |
| Astellas Pharma US Inc | $1,298 | 49 | $0 (2024) |
| PROGENICS PHARMACEUTICALS, INC. | $698.97 | 9 | $0 (2024) |
| Janssen Biotech, Inc. | $650.89 | 39 | $0 (2024) |
| ABBVIE INC. | $582.70 | 20 | $0 (2024) |
| COLOPLAST CORP | $574.55 | 15 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $536.08 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,859 | 60 | PROCEPT BioRobotics Corporation ($1,980) |
| 2023 | $4,995 | 21 | Verathon Inc. ($3,650) |
| 2022 | $899.10 | 10 | Progenics Pharmaceuticals, Inc. ($319.52) |
| 2021 | $2,695 | 40 | Axonics, Inc. ($1,447) |
| 2020 | $797.88 | 38 | Dendreon Pharmaceuticals LLC ($167.84) |
| 2019 | $3,284 | 77 | Boston Scientific Corporation ($1,850) |
| 2018 | $1,272 | 61 | Astellas Pharma US Inc ($263.26) |
| 2017 | $1,462 | 57 | NxThera, Inc. ($329.07) |
All Payment Transactions
364 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $6.38 | General |
| Category: HORMONE THERAPY | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $31.12 | General |
| Category: Oncology | ||||||
| 11/26/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $108.94 | General |
| Category: HORMONE THERAPY | ||||||
| 11/13/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $29.37 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 11/12/2024 | Baxter Healthcare | TISSEEL (Biological) | Food and Beverage | In-kind items and services | $36.06 | General |
| Category: Surgical Care | ||||||
| 10/30/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $59.04 | General |
| Category: HORMONE THERAPY | ||||||
| 10/29/2024 | Laborie Medical Technologies Corp. | Optilume BPH Drug Coated Balloon Catheter (Device) | Food and Beverage | Cash or cash equivalent | $121.57 | General |
| Category: Urology | ||||||
| 10/28/2024 | BLUEWIND MEDICAL | REVI (Device) | Food and Beverage | In-kind items and services | $147.65 | General |
| Category: BLADDER | ||||||
| 10/28/2024 | COLOPLAST CORP | Titan (Device) | Food and Beverage | In-kind items and services | $38.01 | General |
| Category: Men's Health | ||||||
| 10/24/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Diagnostic Imaging | ||||||
| 10/23/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $29.82 | General |
| Category: Oncology | ||||||
| 10/15/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $26.97 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $30.23 | General |
| Category: Oncology | ||||||
| 10/09/2024 | Baxter Healthcare | TISSEEL (Biological) | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: Surgical Care | ||||||
| 10/09/2024 | Endo USA, Inc. | AVEED (Biological), XIAFLEX | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: UROLOGY | ||||||
| 09/24/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/17/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/11/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Oncology | ||||||
| 09/05/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $30.76 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/28/2024 | Astellas Pharma Global Development | Xtandi (Drug) | Food and Beverage | In-kind items and services | $131.61 | General |
| Category: Oncology | ||||||
| 08/21/2024 | COLOPLAST CORP | Luja Coude (Device) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Continence Care | ||||||
| 08/14/2024 | Verathon Inc. | NPD Clinical Study (Device) | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| Category: NPD Clinical Study | ||||||
| 08/14/2024 | 180 Medical, Inc. | GENTLECATH GLIDE (Device) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: CONTINENCE CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 865 | 1,010 | $235,139 | $68,570 |
| 2022 | 13 | 777 | 853 | $218,911 | $66,021 |
| 2021 | 16 | 964 | 1,190 | $183,147 | $71,196 |
| 2020 | 18 | 1,005 | 1,559 | $172,023 | $71,798 |
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 164 | 207 | $64,584 | $20,500 | 31.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 60 | 65 | $43,355 | $13,795 | 31.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 77 | 77 | $36,960 | $10,414 | 28.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 83 | 93 | $20,553 | $6,406 | 31.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 34 | $14,892 | $5,258 | 35.3% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 16 | 16 | $11,344 | $3,105 | 27.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 39 | 39 | $12,246 | $3,005 | 24.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 18 | 18 | $9,155 | $2,256 | 24.6% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 136 | 155 | $10,075 | $1,490 | 14.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 17 | $2,329 | $820.64 | 35.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 166 | 218 | $2,834 | $736.56 | 26.0% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 13 | 19 | $1,349 | $399.76 | 29.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 19 | 19 | $1,406 | $245.10 | 17.4% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 16 | 16 | $3,904 | $101.60 | 2.6% |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | Office | 2023 | 17 | 17 | $153.00 | $37.48 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 145 | 184 | $57,408 | $18,224 | 31.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 64 | 69 | $43,194 | $15,197 | 35.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 90 | 90 | $43,200 | $11,827 | 27.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 73 | 81 | $17,091 | $5,524 | 32.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 30 | 32 | $13,440 | $4,633 | 34.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 51 | 51 | $16,014 | $4,124 | 25.8% |
| 55700 | Biopsy of prostate gland | Office | 2022 | 18 | 18 | $11,946 | $3,928 | 32.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 110 | 119 | $7,735 | $1,075 | 13.9% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2022 | 15 | 15 | $2,150 | $653.72 | 30.4% |
| 81002 | Urinalysis, manual test | Office | 2022 | 135 | 148 | $1,924 | $502.55 | 26.1% |
About Dr. Jeffrey Evans, MD
Dr. Jeffrey Evans, MD is a Urology healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326088014.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Evans, MD has received a total of $20,265 in payments from pharmaceutical and medical device companies, with $4,859 received in 2024. These payments were reported across 364 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($10,511).
As a Medicare-enrolled provider, Evans has provided services to 3,611 Medicare beneficiaries, totaling 4,612 services with total Medicare billing of $277,585. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Seattle, WA
- Active Since 06/08/2006
- Last Updated 08/09/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1326088014
Products in Payments
- NPD Clinical Study (Device) $4,450
- AQUABEAM SYSTEM (Device) $1,980
- AMS (Device) $1,657
- Axonics r-SNM System (Device) $1,392
- PYLARIFY (Drug) $698.97
- XTANDI (Drug) $672.10
- PROVENGE (Drug) $533.98
- Erleada (Drug) $531.06
- ORGOVYX (Drug) $483.72
- FIRMAGON (Drug) $443.21
- JELMYTO (Drug) $391.42
- Nubeqa (Drug) $379.61
- Xtandi (Drug) $364.29
- Rezum (Device) $329.07
- Lupron Depot (Drug) $228.85
- UROLIFT (Device) $227.45
- Lupron (Drug) $224.75
- SPEEDICATH (Device) $195.42
- REVI (Device) $195.20
- TOVIAZ (Drug) $173.79
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Seattle
Dr. James Porter, M.d, M.D
Urology — Payments: $764,015
Cristopher Garlitz, M.d, M.D
Urology — Payments: $303,210
Dr. Thomas Walsh, M.d, M.D
Urology — Payments: $279,672
Marah Hehemann, M.d, M.D
Urology — Payments: $264,034
Una Lee, M.d, M.D
Urology — Payments: $131,923
Alvaro Lucioni, M.d, M.D
Urology — Payments: $57,879